PT Millennium Pharmacon International Tbk
Jakarta Stock Exchange SDPC.JK
PT Millennium Pharmacon International Tbk Free Cash Flow Yield on January 14, 2025: -71.37%
-
PT Millennium Pharmacon International Tbk 52-week high Free Cash Flow Yield is -52.98% on November 22, 2024, which is 25.77% above the current Free Cash Flow Yield.
-
PT Millennium Pharmacon International Tbk 52-week low Free Cash Flow Yield is -75.73% on June 27, 2024, which is -6.10% below the current Free Cash Flow Yield.
-
PT Millennium Pharmacon International Tbk average Free Cash Flow Yield for the last 52 weeks is -66.06%.
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
| CEO | Mr. Ahmad Bin Abu Bakar |
| IPO Date | Sept. 3, 2001 |
| Location | Indonesia |
| Headquarters | Crown Bungur Arteri |
| Employees | 1,172 |
| Sector | Health Care |
| Industries | |
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, dietary supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. As of December 31, 2021, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Past 5 years
USD 0.05
USD 0.01
USD 0.38
USD 0.01
StockViz Staff
January 15, 2025
Any question? Send us an email